Prophylaxis and early outpatient treatment protocol for COVID-19


Front Line COVID-19 Critical Care Alliance | 6 January 2021


Ivermectin, an anti-parasitic medicine whose discovery won the Nobel Prize in 2015, has proven, highly potent, anti-viral and anti-inflammatory properties in laboratory studies. In the past 4 months, numerous, controlled clinical trials from multiple centers and countries worldwide are reporting consistent, large improvements in COVID-19 patient outcomes when treated with Ivermectin.



Latest posts